Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2011

01-02-2011 | Original Paper

Malaise, Motivation and Motherhood: Predictors of Engagement in Behavioral Interventions from a Randomized Controlled Trial for HIV+ Women in Drug Abuse Recovery

Authors: Victoria B. Mitrani, Daniel J. Feaster, Nomi S. Weiss-Laxer, Brian E. McCabe

Published in: AIDS and Behavior | Issue 2/2011

Login to get access

Abstract

Drug abuse has serious consequences for the wellbeing of persons with HIV/AIDS but suboptimal rates of client engagement limit the efficacy of interventions. The present study examines and compares client characteristics that predicted engagement (defined as attendance at two or more sessions) in a family intervention (SET) and a group intervention within a randomized trial aimed at preventing relapse and improving medication adherence for 126 predominantly African American HIV+ women in drug abuse recovery. Intervention engagement (60% overall) was not significantly different across the two interventions. Fewer physical and mental symptoms (malaise) (P < 0.05), living independently (P < 0.05), living with children (P < 0.05), and readiness to change (P < 0.05) were associated with engagement across the two interventions. Results from this study can be used to inform outreach and engagement approaches for women dually affected by drug abuse and HIV/AIDS.
Literature
1.
Klinkenberg WD, Sacks S, HIV/AIDS Treatment, Adherence, and Health Outcomes and Cost Study Group. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16:S22–42.CrossRefPubMed
2.
Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27:251–9.PubMed
3.
Sherbourne C, Forge NG, Kung FY, Orlando M, Tucker J. Personal and psychosocial characteristics associated with psychiatric conditions among women with human immunodeficiency virus. Womens Health Issues. 2003;13:104–10.CrossRefPubMed
4.
Calsyn RJ, Klinkenberg WD, Morse GA, Miller J, Cruthis R, HIV/AIDS Treatment, Adherence, Health Outcomes and Cost Study Group. Recruitment, engagement, and retention of people living with HIV and co-occurring mental health and substance use disorders. AIDS Care. 2004;16:S56–70.CrossRefPubMed
5.
Compton WM, Glantz M, Delany P. Addiction as a chronic illness—putting the concept into action. Eval Program Plan. 2003;26:353–4.CrossRef
6.
Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29:9–53.CrossRef
7.
Copello AG, Templetonb L, Vellemanb R. Family interventions for drug and alcohol misuse: is there a best practice? Curr Opin Psychiatry. 2006;19:271–6.CrossRefPubMed
8.
HIV/AIDS Treatment Adherence, Health Outcomes, Cost Study Group. The HIV/AIDS treatment adherence, health outcomes, and cost study: conceptual foundations and overview. AIDS Care. 2004;16:6–21.CrossRef
9.
Andersen M, Hockman E, Smereck G, et al. Retaining women in HIV medical care. J Assoc Nurses AIDS Care. 2007;18:33–41.CrossRefPubMed
10.
Pillai NV, Kupprat SA, Halkitis PN. Impact of service delivery model on health care access among HIV-positive women in New York City. AIDS Patient Care. 2009;23:51–8.CrossRef
11.
Winiarski MG, Beckett E, Salcedo J. Outcomes of an inner-city HIV mental health programme integrated with primary care and emphasizing cultural responsiveness. AIDS Care. 2005;17:747–56.CrossRefPubMed
12.
Mitrani VB, Szapocznik J, Robinson C. Structural ecosystems therapy with seropositive African American mothers. In: Pequegnat W, Szapocznik J, editors. Inside families: the role of families in preventing and adapting to HIV/AIDS. Rockville: National Institute of Mental Health; 2000. p. 243–80.
13.
Mitrani V, Robinson C, Szapocznik J. Structural ecosystems therapy (SET) for women with HIV/AIDS. In: Stanton M, Bray J, editors. Handbook of family psychology. West Sussex: Wiley-Blackwell; 2009. p. 355–69.CrossRef
14.
Szapocznik J, Feaster DJ, Mitrani VB, et al. Structural ecosystems therapy for HIV-seropositive African American women: effects on psychological distress, family hassles, and family support. J Consult Clin Psychol. 2004;72:288–303.CrossRefPubMed
15.
Feaster DJ, Burns MJ, Brincks AB, et al. Relative efficacy of structural ecosystems therapy in reducing risk of drug abuse relapse for HIV+ African American women. Fam Process. In press.
16.
Feaster DJ, Mitrani VB, Burns MJ, et al. A randomized controlled trial of structural ecosystems therapy for HIV medication adherence and substance abuse relapse prevention. Drug Alcohol Depend. In press.
17.
Lefforge NL, Donohue B, Strada MJ. Improving session attendance in mental health and substance abuse settings: a review of controlled studies. Behav Ther. 2007;38:1–22.CrossRefPubMed
18.
Stanton MD. Getting reluctant substance abusers to engaged in treatment/self-help: a review of outcomes and clinical options. J Marital Fam Ther. 2004;4:165–82.CrossRef
19.
Cleary M, Hunt GE, Matheson SL, Siegfried N, Walter G. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev. 2008;1:Art. No.: CD001088. doi:10.​1002/​14651858.​CD001088.​pub2.
20.
Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47:449–58.CrossRefPubMed
21.
Prado G, Szapocznik J, Mitrani VB, Mauer MH, Smith L, Feaster DJ. Factors influencing engagement into interventions for adaptation to HIV in African American women. AIDS Behav. 2002;6:141–51.CrossRefPubMed
22.
Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention. Psychosom Med. 2003;65:1038–46.CrossRefPubMed
23.
Antoni MH, Carrico AW, Durán RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–51.CrossRefPubMed
24.
Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729–36.CrossRefPubMed
25.
Padgett DK, Henwood B, Abrams C, Davis A. Engagement and retention in services among formerly homeless adults with co-occurring mental illness and substance abuse: voices from the margins. Psychiatr Rehabil J. 2008;31:226–33.CrossRefPubMed
26.
Brown VB, Melchior LA, Panter AT, Slaughter R, Huba GJ. Women’s steps of change and entry into drug abuse treatment: a multidimensional stages of change model. J Subst Abuse Treat. 2000;18:231–40.CrossRefPubMed
27.
DiClemente CC, Schlundt D, Gemmell L. Readiness and stages of change in addiction treatment. Am J Addict. 2004;13:103–19.CrossRefPubMed
28.
Barroso J, Sandelowski M. Substance abuse in HIV-positive women. J Assoc Nurses AIDS Care. 2004;15:48–59.CrossRefPubMed
29.
Wilke DJ, Kamata A, Cash SJ. Modeling treatment motivation in substance-abusing women with children. Child Abuse Negl. 2005;29:1313–23.CrossRefPubMed
30.
Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47:597–606.CrossRefPubMed
31.
Mellins CA, Kang E, Leu C-S, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDS. 2003;17:407–16.CrossRefPubMed
32.
Leaver CA, Bargh G, Dunn JR. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11:S85–100.CrossRef
33.
Szapocznik J, Kurtines WM. Breakthroughs in family therapy with drug abusing and problem youth. New York: Springer; 1989.
34.
Minuchin S, Fishman HC. Family therapy techniques. Cambridge: Harvard University Press; 1981.
35.
Szapocznik J, Hervis O, Schwartz S. Brief strategic family therapy for adolescent drug abuse. NIDA therapy manuals for drug addiction, manual 5. Rockville: US Department of Health and Human Services; 2003.
36.
Baker SA, Beadnell B, Stoner S, et al. Skills training versus health education to prevent STDs/HIV in heterosexual women: a randomized controlled trial utilizing biological outcomes. AIDS Educ Prev. 2003;15:1–14.CrossRefPubMed
37.
Mitrani VB, Prado G, Feaster DJ, Robinson-Batista C, Szapocznik J. Relational factors and family treatment engagement among low-income, HIV+ African American mothers. Fam Process. 2003;42:31–45.CrossRefPubMed
38.
Santisteban DA, Szapocznik J, Perez-Vidal A, Kurtines WM, Murray EJ, Laperriere A. Efficacy of intervention for engaging youth and families into treatment and some variables that may contribute to differential effectiveness. Fam Syst Health. 1996;10:35–44.
39.
Coatsworth JD, Santisteban DA, McBride CK, Szapocznik J. Brief strategic family therapy versus community control: engagement, retention and an exploration of the moderating role of adolescent symptom severity. Fam Process. 2001;40:313–32.CrossRefPubMed
40.
Mitrani VB, Weiss-Laxer NS, Ow CE, Burns MJ, Ross-Russell S, Feaster DJ. Examining family networks of HIV+ women in drug recovery: challenges and opportunities. Fam Syst Health. 2009;27:267–83.CrossRefPubMed
41.
Williams J. Structured interview guide for the Hamilton depression and anxiety scales (SIGH-AD). New York: New York State Psychiatric Institute; 1988.
42.
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.PubMed
43.
44.
McConnaughy EA, Prochaska JO, Velicer WF. Stages of change in psychotherapy: measurement and sample profiles. Psychother Theory Res Pract. 1983;20:368–75.CrossRef
45.
DeLongis A, Folkman S, Lazarus RS. The impact of daily stress on health and mood: psychosocial and social resources as mediators. J Pers Soc Psychol. 1988;54:486–95.CrossRefPubMed
46.
Sarason IG, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: practical and theoretical implications. J Soc Pers Relatsh. 1987;4:497–510.CrossRef
47.
Szapocznik J, Rio AT, Hervis OE, Mitrani VB, Kurtines WM, Faraci AM. Assessing change in family functioning as a result of treatment: the structural family systems rating scale (SFSR). J Marital Fam Ther. 1991;17:295–310.CrossRef
48.
Mitrani VB, Feaster DJ, McCabe BE, Czaja SJ, Szapocznik J. Adapting the structural family systems rating to assess the patterns of interaction in families of dementia caregivers. Gerontologist. 2005;45:445–55.PubMed
49.
Minuchin S, Rosman BL, Baker L. Psychosomatic families: anorexia nervosa in context. Cambridge: Harvard University Press; 1978.
50.
Muthén LK, Muthén BO. Mplus user’s guide. 5th ed. Los Angeles: Muthén and Muthén; 2007.
51.
Bryan A, Schiege SJ, Broaddus MR. Mediational analysis in HIV/AIDS research: estimating multivariate path analytic models in a structural equation modeling framework. AIDS Behav. 2007;11:365–83.CrossRefPubMed
52.
Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18:39–50.CrossRef
53.
Liddle HA, Dakof GA. Efficacy of family therapy for drug abuse: promising but not definitive. J Marital Fam Ther. 1995;21:511–43.CrossRef
54.
West SG, Duan N, Pequegnat W, et al. Alternatives to the randomized controlled trial. Am J Public Health. 2008;98:1359–66.CrossRefPubMed
55.
56.
Rotheram-Borus MJ, Lester P, Song J, et al. Intergenerational benefits of family-based HIV interventions. J Consult Clin Psychol. 2006;74:622–7.CrossRefPubMed
57.
Boyd-Franklin N. Black families in therapy: a multisystems approach. New York: Guilford Press; 1989.
58.
Ledgerwood DM, Alessi SM, Hason T, Godley MD, Petry NM. Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics. J Appl Behav Anal. 2008;41:517–26.CrossRefPubMed
59.
Nock MK, Kazdin AE. Randomized controlled trial of a brief intervention for increasing participation in parent management training. J Consult Clin Psychol. 2005;73:872–9.CrossRefPubMed
60.
Swartz HA, Zuckoff A, Grote N, et al. Engaging depressed patients in psychotherapy: integrating techniques from motivational interviewing and ethnographic interviewing to improve treatment participation. Prof Psychol Res Pract. 2007;38:430–9.CrossRef
61.
Golin CE, Earp J, Tien H, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42–51.CrossRefPubMed
62.
Parsons JT, Rosof E, Punzalan JC, DiMaria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS. 2005;19:31–9.CrossRefPubMed
Metadata
Title
Malaise, Motivation and Motherhood: Predictors of Engagement in Behavioral Interventions from a Randomized Controlled Trial for HIV+ Women in Drug Abuse Recovery
Authors
Victoria B. Mitrani
Daniel J. Feaster
Nomi S. Weiss-Laxer
Brian E. McCabe
Publication date
01-02-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9714-z

Other articles of this Issue 2/2011

AIDS and Behavior 2/2011 Go to the issue

Original Paper

Effectiveness of an HIV Prevention Program for Women Visiting Their Incarcerated Partners: The HOME Project

Original Paper

Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel

Original Paper

Locating the Places People Meet New Sexual Partners in a Southern US City to Inform HIV/STI Prevention and Testing Efforts

Original Paper

Socioeconomic Position and HIV Risk-Relevant Behavior Among Lower-Income Heterosexuals in San Francisco

Original Paper

Notes on the Frequency of Routinely Collected and Self-Reported Behavioral Data in HIV Prevention Trials

Original Paper

Intensive Case Management Before and After Prison Release is No More Effective Than Comprehensive Pre-Release Discharge Planning in Linking HIV-Infected Prisoners to Care: A Randomized Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits